Precigen (PGEN) Cash from Operations (2012 - 2026)
Precigen (PGEN) posted quarterly Cash from Operations of 43827000.0 for Q1 2026, down 168.47% year-over-year from 64013221.35 in Q1 2025, and down 86.82% quarter-over-quarter from 23460000.0 in Q4 2025.
Precigen (PGEN) Cash from Operations (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Cash from Operations for 15 consecutive years, with 43827000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 168.47% year-over-year to 43827000.0; the TTM figure through Mar 2026 stood at 115333000.0 (down 63.81% YoY), while the FY2025 annual figure was 87831000.0, down 28.84% from the prior year.
- Cash from Operations eased to 43827000.0 in Q1 2026 per PGEN's latest filing, from 23460000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 7053000.0 in Q2 2022 and bottomed at 43827000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 19518000.0 across 5 years, with a median of 18388000.0 in 2023.
- Annual changes were most pronounced in 2024 — Cash from Operations soared 47.72% — and 2025, when it tumbled 184.61%.
- Precigen's Cash from Operations stood at 15396000.0 in 2022, then slipped by 2.4% to 15766000.0 in 2023, then jumped by 47.72% to 8243000.0 in 2024, then sank by 184.61% to 23460000.0 in 2025, then plunged by 86.82% to 43827000.0 in 2026.
- Business Quant data shows PGEN's Cash from Operations at 43827000.0 in Q1 2026, 23460000.0 in Q4 2025, and 29069000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Precigen | 2.18 Bn | 2.18 Bn | 52.17 Mn | -17.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.81 Mn |
| Jun 30, 2026 | -17.81 Mn |
| Mar 31, 2026 | -43.83 Mn |
| Mar 31, 2026 | -43.83 Mn |
| Dec 31, 2025 | -23.46 Mn |
| Dec 31, 2025 | -23.46 Mn |
| Sep 30, 2025 | -29.07 Mn |
| Sep 30, 2025 | -29.07 Mn |
| Jun 30, 2025 | -18.98 Mn |
| Jun 30, 2025 | -18.98 Mn |
| Mar 31, 2025 | -16.33 Mn |
| Mar 31, 2025 | -16.33 Mn |
| Dec 31, 2024 | -8.24 Mn |
| Dec 31, 2024 | -8.24 Mn |
| Sep 30, 2024 | -22.73 Mn |
| Sep 30, 2024 | -22.73 Mn |
| Jun 30, 2024 | -23.11 Mn |
| Jun 30, 2024 | -23.11 Mn |
| Mar 31, 2024 | -14.09 Mn |
| Mar 31, 2024 | -14.09 Mn |